Jay Venkatesan - Dec 27, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
President and Chief Executive Officer and Director, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Jay. R. Venkatesan
Stock symbol
ELTX
Transactions as of
Dec 27, 2021
Transactions value $
$730,373
Form type
4
Date filed
12/29/2021, 03:08 PM
Previous filing
Dec 22, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Purchase $171K +66.9K +4.91% $2.55 1.43M Dec 27, 2021 Direct F1
transaction ELTX Common Stock Purchase $560K +210K +14.72% $2.66 1.64M Dec 28, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.55 inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.75 inclusive.

Remarks:

President and Chief Executive Officer and Director